Edition:
United States

BeyondSpring Inc (BYSI.OQ)

BYSI.OQ on NASDAQ Stock Exchange Capital Market

19.56USD
11:06am EDT
Change (% chg)

$-0.12 (-0.61%)
Prev Close
$19.68
Open
$19.40
Day's High
$19.56
Day's Low
$19.28
Volume
2,381
Avg. Vol
4,104
52-wk High
$41.96
52-wk Low
$19.28

Chart for

About

BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $438.45
Shares Outstanding(Mil.): 22.46
Dividend: --
Yield (%): --

Financials

  BYSI.OQ Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -2.70 -- --
ROI: -175.01 2.89 12.63
ROE: -161.81 1.65 14.82

BRIEF-BeyondSpring Says Richard Brand Resigned As CFO

* BEYONDSPRING SAYS RICHARD A. BRAND RESIGNED AS CHIEF FINANCIAL OFFICER OF CO EFFECTIVE AS OF FEBRUARY 20, 2018 - SEC FILING

Feb 21 2018

Earnings vs. Estimates